The Food and Drug Administration recently approved Synjardy XR, a diabetes medication developed by Indianapolis-based Eli Lilly & Co. and Ridgefield, Conn.-based Boehringer Ingelheim Pharmaceuticals.
* U.S. FDA approves supplemental new drug applications to include landmark data in product labels for synjardy (empagliflozin/metformin hydrochloride), synjardy xr (empagliflozin/metformin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results